[Atherogenesis in bronchial asthma patients: its relationship to the pathogenetic characteristics of the disease and to liver function (the clinico-biochemical aspects)].
Ten asthmatics in remission and aggravation of the disease were examined for: lipoprotein pre-beta, beta and alpha fractions, total cholesterol and its fractions in atherogenic and antiatherogenic lipoproteins with estimation of the atherogenicity coefficient, activity of 5-nucleotide hydrolase, acid phosphatase, gamma-glutamyl transpeptidase and alcohol dehydrogenase. The results were indicative of more active atherosclerotic process in the presence of blockade which changed the activity of hepatocyte membrane lipoprotein receptors, of simultaneous operation in bronchial asthma patients of infiltrative and cellular mechanisms of atherosclerosis.